Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Public ClinicalTrials.gov record NCT02348918. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 2 Multi center, Randomized, Controlled, Double-Masked Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of Luminate® (Alg-1001) As Compared To Avastin® In The Treatment Of Diabetic Macular Edema
Study identification
- NCT ID
- NCT02348918
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 218 participants
Conditions and interventions
Conditions
Interventions
- Luminate 1.0mg Drug
- Luminate 2.0mg Drug
- Luminate 3.0mg Drug
- Avastin Drug
- Luminate 0.5mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 13, 2014 (Actual)
- Primary completion
- May 16, 2017 (Actual)
- Completion
- Jun 13, 2017 (Actual)
- Last update posted
- Dec 7, 2018
2014 – 2017
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Associated Retina Consultants | Phoenix | Arizona | 85020 | — |
| Retina Vitreous Associates Medical Group | Beverly Hills | California | 90211 | — |
| Northern California Retina Vitreous Associates | Mountain View | California | 94040 | — |
| West Coast Retina | San Francisco | California | 94109 | — |
| Orange County Retina Medical Group | Santa Ana | California | 92705 | — |
| New England Retina Associates | New London | Connecticut | 06320 | — |
| Florida Eye Clinic | Altamonte Springs | Florida | 32701 | — |
| Retina Specialty Institute | Pensacola | Florida | 32503 | — |
| Center for Retina and Macular Disease | Winter Haven | Florida | 33880 | — |
| Wilmer Eye Institute at John Hopkins University | Baltimore | Maryland | 21205 | — |
| TLC Eye Group | Jackson | Michigan | 49202 | — |
| Island Retina | Shirley | New York | 11967 | — |
| Charlotte EENT Associates | Charlotte | North Carolina | 28210 | — |
| Black Hills Regional Eye Institute | Rapid City | South Dakota | 57701 | — |
| Austin Retina Associates | Austin | Texas | 78705 | — |
| Retina Consultant of Houston | Houston | Texas | 77098 | — |
| Spokane Eye Clinical Research | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02348918, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 7, 2018 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02348918 live on ClinicalTrials.gov.